Richard W. Mott is Director at TREACE MEDICAL CONCEPTS, INC. (TMCI). They have made 16 open-market trades across 1 company since 2022, most recently 2025-05-20.
CIK 0001210226
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $1.2M since 2024, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TMCI | 1,096,861 | $4.3M |
Shares reported on the most recent Form 4, priced at the 2025-05-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TMCI | BUY | 2024-05-24 | 2024-05-28 | $5.19 | $93K | +18.4% | +33.1% | +25.9% |
| TMCI | BUY | 2024-05-22 | 2024-05-23 | $4.99 | $60K | +17.5% | +11.3% | +24.0% |
| TMCI | BUY | 2024-05-10 | 2024-05-13 | $4.51 | $1.1M | -1.0% | +19.3% | +11.8% |
| TMCI | SELL | 2023-04-06 | 2023-04-10 | $26.00 | $105K | -3.2% | -3.8% | -14.4% |
| TMCI | SELL | 2023-04-03 | 2023-04-05 | $26.00 | $415K | -1.9% | +2.4% | -6.5% |
| TMCI | SELL | 2023-03-30 | 2023-03-31 | $25.54 | $3.4M | +3.1% | +3.5% | -1.9% |
| TMCI | SELL | 2023-03-08 | 2023-03-10 | $23.26 | $1.1M | +0.3% | +15.6% | +9.2% |
| TMCI | SELL | 2023-03-01 | 2023-03-03 | $21.35 | $1.1M | +11.0% | +22.9% | +25.7% |
| TMCI | SELL | 2023-02-02 | 2023-02-03 | $24.00 | $96K | -10.5% | -17.0% | +8.1% |
| TMCI | SELL | 2023-01-30 | 2023-01-30 | $23.24 | $4.2M | -9.4% | -8.9% | +12.6% |
| TMCI | SELL | 2023-01-17 | 2023-01-19 | $26.00 | $286K | -11.0% | -15.6% | -0.2% |
| TMCI | SELL | 2023-01-12 | 2023-01-13 | $26.00 | $1.3M | -2.7% | -17.8% | -0.1% |
| TMCI | SELL | 2023-01-05 | 2023-01-09 | $24.00 | $480K | +13.6% | -8.1% | +20.0% |
| TMCI | SELL | 2022-12-30 | 2022-12-30 | $22.67 | $3.4M | +10.9% | +0.2% | +10.8% |
| TMCI | SELL | 2022-11-30 | 2022-12-02 | $22.34 | $2.1M | +0.0% | -6.8% | -14.8% |
| TMCI | SELL | 2022-10-31 | 2022-11-01 | $23.57 | $2.2M | +5.2% | +6.1% | +0.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.